Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis
Mikkel Højlund, Helin Yılmaz Kafalı, Begüm Kırmızı, Paolo Fusar‐Poli, Christoph U. Correll, Samuele Cortese, Michel Sabé, Jess G. Fiedorowicz, Gayatri Saraf, Josephine Zein, Michael Berk, M. Ishrat Husain, Joshua D. Rosenblat, Ruby Rubaiyat, Kim Corace, Stanley Wong, Simon Hatcher, Mark Kaluzienski, Lakshmi N. Yatham, Andrea Cipriani, Corentin J. Gosling, Robin Carhart‐Harris, Peter Tanuseputro, Daniel T. Myran, Nicholas Fabiano, David Moher, Leah M. Mayo, Stuart G. Nicholls, Tracy White, Michele De Prisco, Joaquim Raduà, Eduard Vieta, Karim S. Ladha, Jay Katz, Areti Angeliki Veroniki, Marco Solmi (2025). Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis. , 101, DOI: https://doi.org/10.1016/j.euroneuro.2025.09.011.
